Journal profile · Psychology
Psycho-Oncologie
ISSN 1778-3798 · eISSN 1778-381X · Lavoisier · FRANCE · Quarterly · Founded 2007
Psycho-Oncologie: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.44; hybrid open access; review over 12 weeks (community reports); community-reported acceptance: easy; 188 articles in 2025; indexed in SCIE and Scopus; the journal's website says submissions are paused or closed.
The journal's website says submissions are paused or closed: Psycho-Oncologie is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites. Source ↗Publisher website ·
Scope
Aims, scope and focus
Psycho-Oncologie is published by Lavoisier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Health, Medicine and Society, Cancer survivorship and care and Psychoanalysis and Psychopathology Research, together about 42.6% of its articles. Its main subfields are General Health Professions. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Psychology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Health, Medicine and SocietyHealth Professions18.8%
- Cancer survivorship and careMedicine13.4%
- Psychoanalysis and Psychopathology ResearchPsychology10.4%
- Family Support in IllnessSocial Sciences8.2%
- Healthcare Systems and PracticesHealth Professions7.8%
- Childhood Cancer Survivors' Quality of LifeMedicine6.7%
- Social Policies and FamilySocial Sciences5.4%
- Palliative Care and End-of-Life IssuesMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Psychology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Psychology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Psychology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.44LetPub ·
- CiteScore 2026-06
- 0.5LetPub ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.25LetPub ·
- h-index
- 9LetPub ·
- h-index
- 17OpenAlex ·
- i10-index
- 59OpenAlex ·
- 2-year mean citedness
- 0.3OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 81.32%LetPub ·
Volume
- Articles per year
- 113LetPub ·
Articles by year OpenAlex count · 1,351 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 138 | 138 | 5 |
| 2025 | 188 | 188 | 34 |
| 2024 | 42 | 41 | 73 |
| 2023 | 38 | 29 | 43 |
| 2022 | 37 | 21 | 27 |
| 2021 | 29 | 5 | 17 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lavoisier
- Country or region
- FRANCE
- Language
- French
- Frequency
- Quarterly
- Founded
- 2007
- ISSN
- 1778-3798
- Electronic ISSN
- 1778-381X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Psycho-Oncologie
What CAS zone is Psycho-Oncologie in?
In the 2025 upgraded edition of the CAS Journal Ranking, Psycho-Oncologie is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Psychology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Psycho-Oncologie?
The latest impact factor listed by LetPub is 0.44; CiteScore 0.5, h-index 17.
How long does peer review take at Psycho-Oncologie?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Psycho-Oncologie?
According to LetPub and DOAJ records, Psycho-Oncologie is indexed in SCIE and Scopus.
Is Psycho-Oncologie open access, and what is the APC?
Psycho-Oncologie is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .